XML Print


1- Department of Exercise Physiology,E-Campus Branch, Islamic Azad University, Tehran, Iran
2- Department of Exercise Physiology, Faculty of Biological Sciences, Vap.C. Islamic Azad University, Varamin, Iran , namenifarah@gmail.com
Abstract:   (45 Views)
Background: This study aimed to investigate the modulating effects of two interventions, glycyrrhizin and swimming exercise, on the expression of CXCR4 and CXCL12 genes in the blood and heart tissue of diabetic rat models.
Methods: A total of 55 male Wistar rats were purchased, of which 44 were subcutaneously injected with streptozotocin between the ears. Four days post-injection, blood glucose levels were assessed. Rats exhibiting levels above 250 mg/dL were classified as diabetic and subsequently randomized into four groups of 11 animals each (diabetic control, diabetic + glycyrrhizin, diabetic + swimming training, and diabetic + swimming training + glycyrrhizin). The healthy control group consisted of 11 rats. Two groups of diabetic rats were treated with glycyrrhizin. The core experimental protocol involved swimming training, which was implemented in two of the experimental groups. Glycyrrhizin was dissolved in 0.9% saline with sterile distilled water and administered by gavage at a dose of 120 mg/kg on average, transferred to the stomach of the animals every night. The main experimental protocol consisted of eight weeks of swimming training, which was performed in two experimental groups. The swimming training time started from 25 minutes with 7 liters of water in the adaptation period and increased to 60 minutes of activity in 17 liters of water in the eighth week. After eight weeks, the rats were anesthetized with ketamine and xylazine before blood collection, and then blood samples were taken from their hearts. Data analysis was performed using two-way analysis of variance and Tukey's test.
Results: A marked reduction in the expression levels of CXCR4 and CXCL12 was observed in the groups subjected to exercise and glycyrrhizin supplementation, indicating the potential of these interventions in modulating inflammatory signaling pathways (p<0.05). The greatest reduction in CXCR4 (49.77%) and CXCL12 (68.19%) was observed in the combined exercise + glycyrrhizin group, indicating a stronger effect of the combined therapy than the single treatments.
Conclusion: Swimming training combined with glycyrrhizin supplementation significantly downregulated the expression of CXCR4 and CXCL12 genes and demonstrated potent antioxidant and anti-inflammatory effects, contributing effectively to the modulation and prevention of diabetes.

 
     
Type of Article: Original article | Subject: Health
Received: 2025/03/13 | Accepted: 2025/09/23

References
1. Caturano A, D'Angelo M, Mormone A, Russo V, Mollica MP, Salvatore T, et al. Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications. Curr Issues Mol Biol. 2023;45(8):6651-66. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. García-Cuesta EM, Santiago CA, Vallejo-Díaz J, Juarranz Y, Rodríguez-Frade JM, Mellado M. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases. Front Endocrinol (Lausanne). 2019;10:585. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Gharibi S, Aghaei S, Shahvazian E, Mahmoodi M B, Sahami-Fard M H, kolahdouz P et al. Association of CXCL12 and CXCR4 Genes Polymorphism with Proliferative Diabetic Retinopathy in Diabetic Patients. JSSU. 2022;30(7):5032-41. [View at Publisher] [DOI] [Google Scholar]
4. Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, et al. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed Pharmacother. 2023;168:115734. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Abasubong KP, Adjoumani JJY, Jiang GZ, Liu WB, Li XF, Cao xf, et al. Licorice (Glycyrrhiza glabra) and its derivative (Glycyrrhizic and glycyrrhetinic acid) in finfish aquaculture: A review. Aquaculture Reports. 2024;39:102509. [View at Publisher] [DOI] [Google Scholar]
6. Jeong JH, Lee DH, Song J. HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation. Biomed Pharmacother. 2022;150:112933. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Jurel P, Bahadur S, Bajpai M. Emerging trends in pharmacological and therapeutic potential of glycyrrhizic acids: Traditional and Nano technological approach. Pharmacological Research - Modern Chinese Medicine. 2024;12:100461. [View at Publisher] [DOI] [Google Scholar]
8. Khalid M, Petroianu G, Adem A. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules. 2022;12(4):542. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Canbay E, Kocamanoglu M, Fedacı C, Copur O, Unlu M, Akcay Y, et al. The effect of Glycyrrhiza glabra (Licorice root) extracts on inhibition of 3Clpro. Ege Journal of Medicine / Ege Tıp Dergisi. 2024;63 (2):271-81. [View at Publisher] [DOI] [Google Scholar]
10. Zhou XR, Wang XY, Sun YM, Zhang C, Liu KJ, Zhang FY, et al. Glycyrrhizin Protects Submandibular Gland Against Radiation Damage by Enhancing Antioxidant Defense and Preserving Mitochondrial Homeostasis. Antioxidant Redox Signal. 2024;41(10-12):723-43. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Małkowska P. Positive Effects of Physical Activity on Insulin Signaling. Curr Issues Mol Biol. 2024;46(6):5467-87. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Vidaković M, Grdović N, Dinić S, Mihailović M, Uskoković A, Arambašić Jovanović J. The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus Attenuation. Front Immunol. 2015;6:403. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Cao ZY, Liu YZ, Li JM, Ruan YM, Yan W-J, Zhong S-Y,et al. Glycyrrhizic acid as an adjunctive treatment for depression through anti-inflammation: A randomized placebo-controlled clinical trial. J Affect Disord. 2020:265:247-54. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Umarov A, Djabborov BI, Rakhmatova MR, Durdiev NK, Yuldashev JI, et al.A systematic review of antioxidant and antimicrobial activities in the different extracts of licorice as a valuable plant for ameliorating respiratory infectious disorders. Caspian Journal of Environmental Sciences. 2025; 23(1):269-80. [View at Publisher] [DOI] [Google Scholar]
15. Babaei F, Barzegari A, Nourian E, Dashti Khoydaki MH. Effect of 12 weeks of submaximal swimming training on MAPK and MDA biomarkers in rats exposed to tobacco-derived nitrosamine ketone. Exerc Physiol. 2023;14(56):147-6. [View at Publisher] [DOI] [Google Scholar]
16. Maleki N, Parandin R, Yousofvand N, Khanahmadi M. Anti-inflammatory and anti-nociceptive effects of extract contains and without Glycyrrhizic acid of Glycyrrhiza glabra rhizome in male mice. J Shahrekord Univ Med Sci. 2017;19(5):71-83. [View at Publisher] [Google Scholar]
17. Murck H, Karailiev P, Karailievova L, Puhova A, Jezova D. Treatment with Glycyrrhiza glabra Extract Induces Anxiolytic Effects Associated with Reduced Salt Preference and Changes in Barrier Protein Gene Expression. Nutrients. 2024;16(4):515. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Yang Y, Li J, Lei W, Wang H, Ni Y, Liu Y, et al. CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications. Int J Biol Sci. 2023; 19(11):3341-59. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Oh H, Choi A, Seo N, Lim JS, You JS, Chung YE. Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on post-contrast acute kidney injury. Sci Rep. 2021;11(1):15625. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Rathjen T, Kunkemoeller B, Cederquist CT, Wang X, Lockhart SM, Patti JC, et al. Endothelial Cell Insulin Signaling Regulates CXCR4 (C-X-C Motif Chemokine Receptor 4) and Limits Leukocyte Adhesion to Endothelium. Arterioscler Thromb Vasc Biol. 2022;42(7): 217-27. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Cao M, Zuo J, Yang J-G, Wu C, Yang Y, Tang W, et al. Physiology-Based Pharmacokinetic Study on 18β-Glycyrrhetic Acid Mono-Glucuronide (GAMG) Prior to Glycyrrhizin in Rats. Molecules. 2022;27(14):4657. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Li XQ, Zhang ZL, Tan WF, Sun XJ, Ma H. Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord. PLoS One. 2016;11(10):e0163807. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Isles HM, Herman KD, Robertson AL, Loynes CA, Prince LR, Elks PM, et al. The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in Zebrafish. Front Immunol. 2019:10:1784. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Pahlavani HA. Exercise-induced signaling pathways to counteracting cardiac apoptotic processes. Front Cell Dev Biol. 2022;10:950927. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Wang L, Zhu R, He C, Li H, Zhang Q, Cheung YM, et al. Licorice Extract Isoliquiritigenin Protects Endothelial Function in Type 2 Diabetic Mice. Nutrients. 2024;16(18):3160. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Yin YY, Ton SH, Kadir KBA. Effects of Glycyrrhizic acid on 11 β-Hydroxysteroid Dehydrogenase (11 βHSD1 and 2) Activities and HOMA-IR in Rats at Different Treatment Periods. Exp Clin Endocrinol Diabetes. 2010;118(9):617-24. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Zhang J, Xu HX, Zhu JQ, Dou YX, Xian YF, Lin ZX. Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment. Int J Biol Sci. 2023; 19(10):3029-41. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Plaza-Diaz J, Izquierdo D, Torres-Martos Á, Baig AT, Aguilera CM, Ruiz-Ojeda FJ. Impact of Physical Activity and Exercise on the Epigenome in Skeletal Muscle and Effects on Systemic Metabolism. Biomedicines. 2022;10(1):126. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Halasy V, Szőcs E, Soós Á, Kovács T, Pecsenye-Fejszák N, Hotta R, et al. CXCR4 and CXCL12 signaling regulates the development of extrinsic innervation to the colorectum. Development. 2023;150(8):dev201289. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Nascimento MHM, de Araújo DR. Exploring the Pharmacological Potential of Glycyrrhizic Acid: From Therapeutic Applications to Trends in Nanomedicine. Future Pharmacol. 2022;2(1):1-15. [View at Publisher] [DOI] [Google Scholar]
31. Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol. 2020;13(1):91. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Werner L, Guzner-Gur H, Dotan I. Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease. Theranostics. 2013;3(1):40-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Sadeghi M, Dehnavi S, Asadirad A, Xu S, Majeed M, Jamialahmadi T, et al. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases. Inflammopharmacology. 2023;31(3):1069-93. [View at Publisher] [DOI] [PMID] [Google Scholar]
34. Gaur A, Maity R, Dhali A, Biswas J. Impact of poorly controlled type II diabetes mellitus on chemoresistance in colorectal cancer. World J Gastroenterol .2025;31(11):104065. [View at Publisher] [DOI] [PMID] [Google Scholar]
35. Wang Y, Fang J, Liu B, Shao C, Shi Y. Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell. 2022;29(11):1515-30. [View at Publisher] [DOI] [PMID] [Google Scholar]
36. Sarallah R, Jahani S, Soltani Khaboushan A, Kian Moaveni A, Amiri M, Majidi Zolbin M. The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases. Brain Behav Immun Health. 2025:43:100932 [View at Publisher] [DOI] [PMID] [Google Scholar]
37. Huang D, Lin D, Liang S, Lin J. Expression of CXCR4 in the Primary Lesion of Recurrent Metastatic Breast Cancer and Its Association with Prognosis. Int J Gen Med. 2025;18:1543-53. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb